 - Subjects must have received an adequate trial of colchicine defined as treatment of at least 1.5 mgd for at least 3 months if 6 years old or 1.2 mgd if less than 6 years, or an inability to tolerate colchicine due to adverse effects in a dose that controls acute attacks in the frequency of less than one attack per month. 